Zakirova A N
Ter Arkh. 1995;67(4):33-5.
Ceruloplasmin- and placebo-treated CHD patients were studied for severity of angina pectoris, changes in central hemodynamics, exercise tolerance. It is shown that ceruloplasmin promoted an increase in exercise tolerance, higher quality of life, arrest of the disease progress. Combined treatment of CHD incorporating ceruloplasmin produced a positive effect on central hemodynamics and contractile, pump capacities of the myocardium.
对接受血浆铜蓝蛋白和安慰剂治疗的冠心病患者的心绞痛严重程度、中心血流动力学变化及运动耐量进行了研究。结果表明，血浆铜蓝蛋白可提高运动耐量、改善生活质量并阻止疾病进展。将血浆铜蓝蛋白纳入冠心病的联合治疗对中心血流动力学以及心肌的收缩和泵血能力产生了积极影响。
